Market News How it works Learn FAQ
| RCT 0.1222 60.58% | NU 12.375 -18.37% | EWZ 33.44 -21.48% | TGL 0.2449 10.56% | BBD 2.87 -29.48% | SRTM 0.3384 -21.36% | ITUB 7.555 -21.87% | AZTR 1.72 140.56% | XP 15.775 -48.13% | NVD 4.02 -4.06% | SHFS 0.0979 -26.06% | SPCX 148.81 0.89% | CLRO 4.75 46.15% | SOXL 90.94 8.83% | GCDT 0.1442 -18.11% | PBR 22 -15.90% | NWGL 0.0822 0.24% | VALE 11.895 -4.07% | TSLL 10.9402 12.09% | INTC 90.94 4.58% | SGRY 23.095 46.63% | CRWV 56.79 4.71% | NVDA 215.6 2.20% | BITO 10.6301 -1.85% | GPUS 0.1862 10.24% | SOXS 47.855 -8.78% | RBNE 0.17 -10.53% | NOK 8.6738 6.56% | ABEV 2.78 -15.76% | RWM 14.455 -0.65% | IREN 26.12 4.88% | JBLU 2.2648 -13.72% | INTR 4.525 -37.07% | TSLG 5.4701 12.32% | SBS 4.615 -27.89% | TQQQ 68.649 3.56% | XTND 2.1 18.64% | SPRC 1.5 37.61% | SPDN 8.4901 -0.58% | TSLA 395.035 6.13% | AAL 12.1593 0.41% | LUCD 0.5437 32.29% | SID 0.9326 -20.97% | SQQQ 38.275 -3.54% | PBR-A 19.3171 -17.90% | CIFR 7.9 -0.50% | GGB 4.725 -7.35% | T 21.035 0.50% | QID 14.195 -2.44% | NFLX 63.265 -3.93%
MDMiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG)

NASDAQ Capital Market · Currency in USD
$3.88 ▼ -0.04 (-0.90%)
As of Oct 26, 1:19 PM ET. Market open.

Summary

Previous Close
$3.91
Open
$3.91
Day's Range
$3.84 – $3.92
52 Week Range
$3.03 – $7.97
Volume
389,522
Avg. Volume
1,299,460
Market Cap
$564.82M
Beta (5Y Monthly)
1.42
PE Ratio (TTM)
96.88
EPS (TTM)
$0.04
Earnings Date
Oct 28, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$7.67

Profile: MiMedx Group, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
808
CEO
Joseph H. Capper
Website
mimedx.com

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy.

Earnings

Next report: Wed, Oct 28, 2026
EPS estimate $0.00 · Revenue est. $68.56M
DateEst.Actual
Jul 29, 2026-$0.05-$0.05Miss
Apr 29, 2026-$0.07-$0.05Beat
Feb 25, 2026$0.09$0.14Beat
Oct 29, 2025$0.07$0.15Beat
Jul 30, 2025$0.06$0.10Beat
Apr 30, 2025$0.06$0.06Beat

Analyst view

Consensus price target
$7.67 ▲ +97.9%
Range $7.00 – $8.00
Rating: Buy
Buy 80% · Hold 7% · Sell 13%

Get free alerts on MDXG and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.